Industry and healthcare professionals collaborate in a range of activities in preclinical research, clinical development as well as clinical practice and patient outcome.
As the primary point of contact with patients, healthcare professionals offer invaluable and expert knowledge on patient outcomes and the management of diseases. This plays a crucial role in optimizing our efforts to improve patient care, treatment options and patient outcomes.
Patients can only truly benefit from the huge amount of invaluable medical knowledge that exists worldwide when our internal experts work closely together with external researchers and healthcare professionals. We strongly believe that the joint use of this expertise will help us to gain a better understanding of major diseases and to develop better medicines faster. The treating physician and other healthcare professionals conduct clinical trials at study centers in accordance with the clinical study protocol as approved by health authorities, institutional review boards, and ethics committees. Thus, they are the major link to the participating patients and are responsible for collecting data. Expertise and time offered by healthcare professionals and healthcare organizations in the course of a clinical trial need to be compensated.
Bayer develops innovative medicines. Novel treatments have to be introduced and explained to healthcare professionals to ensure their responsible use. Therefore, we support the education of healthcare professionals at congresses and trainings. This contributes to ensuring doctors have access to the latest medical research and are thus able to prescribe the best treatment option for their patients. Only then can we fulfill our commitment to support the correct use of our new treatments. Scientific events are just one of many resources for physician’s education.